Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Notal Vision announced that the FDA has granted De Novo authorization for its patient self-operated Scanly Home OCT device. Designated by the FDA as a breakthrough device for patients suffering from wet age-related macular degeneration (AMD), Scanly Home OCT aims…
Generative artificial intelligence in ophthalmology ScienceDirect.com Source: Author: | Date: 2024-05-16 22:31:00 Source: Author: | Date: 2024-05-16 22:31:00

The University of Missouri School of Medicine has revealed that the virus responsible for COVID-19 can penetrate the blood-retinal barrier, potentially causing long-term eye complications. The blood-retinal barrier is a crucial defense mechanism, protecting our vision from infections by preventing…

A study led by a University at Buffalo researcher has the potential to revolutionize the treatment of retinopathy of prematurity (ROP), a condition that can lead to blindness in low birthweight premature infants if left untreated. Published in eClinicalMedicine, the…

ArcScan, a global medical technology company dedicated to revolutionizing ophthalmic care, marked a significant milestone with the announcement of the National Medical Products Administration (NMPA) approval of its flagship product, the ArcScan Insight® 100, for use in China. Addressing the…

Humonix Biosciences, a pioneering biotechnology company, has recently named Dr. Karen Torrejon as its new Chief Executive Officer. Dr. Torrejon, who originally founded the company in 2014, will now lead its operations as it transitions into a broader, science-driven platform.…

Researchers have developed a prototype “smart” contact lens that accurately measures eye pressure regardless of temperature, according to a study in ACS Applied Materials & Interfaces. Around 3 million people in the U.S. suffer from glaucoma, according to the Centers…

Topcon Healthcare announced a partnership with Microsoft Corporation to deliver AI-powered ‘Healthcare from the Eye’ solutions to improve healthcare access, cost, and quality. A cloud-based connected network of healthcare providers using the ‘Nuance Precision Imaging Network’ and the THI Harmony…

Retinopathy of Prematurity is one of the critical challenges in neonatal care, especially for premature babies born before 31 weeks of gestation and known as grams weighing less than 1,500. This disease, expressing itself as impaired or even complete abnormalities in…

Oculis has completed enrollment in its multicenter, randomized, double-blind, placebo-controlled phase 2 ACUITY trial evaluating the safety and tolerability of OCS-05 in patients with Acute Optic Neuritis (AON). Topline results are expected in Q4 2024. The phase 2 ACUITY study…